CNCR

March-Madness-Whos-Your-Final-Four.

March Madness for ETFs: 10 Funds Leading the Pack

By Amiya MorettaMarch 13, 2018

Biotech ETFs Pop on Celgene, Juno Deal

Biotech ETFs Pop on Celgene, Juno Deal

By Max ChenJanuary 22, 2018

Biotech ETFs Jump on Gilead, Kite Deal

Biotech ETFs Jump on Gilead, Kite Deal

By Max ChenAugust 28, 2017

etf-performance-report-october

ETF Performance Report: October

By Max ChenNovember 1, 2016

Pfizer Acquires Medivation, Renewis Biotech M&A Bets

Pfizer Acquires Medivation, Renews Biotech M&A Bets

By Max ChenAugust 22, 2016

Health Care ETFs Can Still Strengthen on Increased M&A Activity

Health Care ETFs Can Still Strengthen on Increased M&A Activity

By Max ChenApril 28, 2016

Silver Lining for Biotechnology ETFs After Pfizer Calls off Deal with Allergan

Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal

By Max ChenApril 6, 2016

ETF Trends

The First Cancer Immunotherapy ETF

By Tom LydonOctober 14, 2015